Concepedia

Kim Hulburd

KH

Statistics

Publications

3

Citations

251

H-Index

3

Active since

1998

Affiliations

The Barbara Ann Karmanos Cancer Institute(Current)

Wayne State University

Kim Hulburd is an author at The Barbara Ann Karmanos Cancer Institute specializing in hematologic malignancy pharmacotherapy, hematologic malignancy therapy, and chemotherapy in hematologic malignancies.

Publications per year

1998–2001

3

Publications

3

Phase I study of bryostatin 1 in patients with relapsed non-Hodgkin's lymphoma and chronic lymphocytic leukemia.

Mary Varterasian, Ramzi M. Mohammad, D. Eilender et al. · Journal of Clinical Oncology · 1998 · 112 citations

, , +16

Phase II trial of bryostatin 1 in patients with relapsed low-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia.

Mary Varterasian, Ramzi M. Mohammad, Muhammad Shurafa et al. · PubMed · 2000 · 97 citations

, , +17

Phase II Study of Bryostatin 1 in Patients with Relapsed Multiple Myeloma

Mary Varterasian, Pamela Pemberton, Kim Hulburd et al. · Investigational New Drugs · 2001 · 42 citations

, , +15

1–3 of 3